LightSource CEO, Spencer Penn discusses how funding is helping the business to harness automation for procurement, and the ...

Emcure Pharmaceuticals made its market debut on July 10, 2024. The shares of the Pune-based company have risen 27% against ...

Significant advances in innovative cooling technologies in past year lowered power usage effectiveness (PUE) in subtropical ...

Shares of Emcure Pharmaceuticals slipped 2 per cent on Friday morning following a large block deal worth Rs 574 crore, in ...

Shares of Nuvama Wealth sank over six percent after SEBI restrained Jane Street Group from accessing the local securities ...

At the end of the March quarter, BC Investments IV Ltd., the Bain Capital entity, held 8.68% stake in the company.

Indian equity markets may begin trade on a muted note, tracing mixed global cues. The GIFT Nifty was down 0.17% at 25516.7 ...

According to sources, Bain Capital-backed BC Investments IV might sell a 2.4 percent stake in the firm for Rs 551 crore ...

BC Investments IV, linked to Bain Capital, is expected to sell a 2.4% stake in Emcure Pharmaceuticals. The sale will occur ...

Shares of Emcure Pharma shall be in focus during the trading session on Friday as Bain Capital-affiliated entity BC ...

Blockchain isn’t a speculative detour; it’s a modern financial operating system. And for asset managers, it offers not just ...

The floor price for the transaction has been set at ₹1,279.80 per share, representing a likely discount to the prevailing ...